Impaired vascular reactivity in patients with chronic kidney disease
- PMID: 17960060
- DOI: 10.1159/000110091
Impaired vascular reactivity in patients with chronic kidney disease
Abstract
Background: Patients with chronic kidney disease (CKD) show increased cardiovascular morbidity. We hypothesized that vascular properties which can be routinely evaluated noninvasively are related to different stages of CKD and their clinical and biochemical characteristics.
Methods: Arterial vascular properties were quantified by the reflective index using digital photoplethysmography in 260 patients with CKD. Patients were grouped according to estimated glomerular filtration rate (eGFR). Additional measurements were performed in 50 healthy control subjects.
Results: In patients with CKD stage 1 and 2 (n = 115; age 65 +/- 1 years) the reflective index was 30 +/- 1%, whereas in patients with CKD stage 3 and 4 (n = 60; age 72 +/- 1 years) the reflective index was 36 +/- 1%, and in patients with CKD stage 5 (n = 85; age 64 +/- 1 years) the reflective index was 36 +/- 1% (p < 0.01 by Kruskal-Wallis test) indicating increased arterial stiffness in advanced CKD. Arterial vascular reactivity was significantly impaired in patients with advanced stages of CKD (stage 1 and 2, 78 +/- 12%; stage 3 and 4, 32 +/- 12%; stage 5, 33 +/- 12%; p < 0.01). Univariate analysis showed a significant correlation of the reflective index and eGFR (Pearson r = -0.24; p < 0.0001). Multivariate regression analysis showed an independent association of the reflective index and eGFR (adjusted correlation coefficient, -0.24; p < 0.001).
Conclusion: The advanced stages of CKD are associated with increased vascular stiffness and impaired vascular reactivity and these changes are already present in CKD stage 3 and 4.
2007 S. Karger AG, Basel
Similar articles
-
Stepwise increase in arterial stiffness corresponding with the stages of chronic kidney disease.Am J Kidney Dis. 2005 Mar;45(3):494-501. doi: 10.1053/j.ajkd.2004.11.011. Am J Kidney Dis. 2005. PMID: 15754271
-
Association between body mass index and body fat in chronic kidney disease stages 3 to 5, hemodialysis, and peritoneal dialysis patients.J Ren Nutr. 2008 Sep;18(5):424-9. doi: 10.1053/j.jrn.2008.04.001. J Ren Nutr. 2008. PMID: 18721737
-
Influence of obesity on progression of non-diabetic chronic kidney disease: a retrospective cohort study.Nephron Clin Pract. 2009;113(1):c16-23. doi: 10.1159/000228071. Epub 2009 Jul 10. Nephron Clin Pract. 2009. PMID: 19590231
-
The pros and cons of staging chronic kidney disease.Ethn Dis. 2010 Winter;20(1):77-81. Ethn Dis. 2010. PMID: 20178187 Review.
-
Diagnosing chronic kidney disease.Curr Opin Nephrol Hypertens. 2010 Mar;19(2):123-8. doi: 10.1097/MNH.0b013e328335f951. Curr Opin Nephrol Hypertens. 2010. PMID: 20040867 Review.
Cited by
-
Nrf2 Activation in Chronic Kidney Disease: Promises and Pitfalls.Antioxidants (Basel). 2022 Jun 3;11(6):1112. doi: 10.3390/antiox11061112. Antioxidants (Basel). 2022. PMID: 35740009 Free PMC article. Review.
-
Arterial stiffness and renal impairment in non-proteinuric type 2 diabetic patients.J Diabetes Investig. 2012 Feb 20;3(1):86-91. doi: 10.1111/j.2040-1124.2011.00146.x. J Diabetes Investig. 2012. PMID: 24843550 Free PMC article.
-
Does chronic kidney disease modify the association between body mass index and cardiovascular disease risk factors.J Nephrol. 2012 May-Jun;25(3):317-24. doi: 10.5301/JN.2011.8454. J Nephrol. 2012. PMID: 21725923 Free PMC article.
-
Relationship between stage of kidney disease and incident heart failure in older adults.Am J Nephrol. 2011;34(2):135-41. doi: 10.1159/000328905. Epub 2011 Jul 4. Am J Nephrol. 2011. PMID: 21734366 Free PMC article.
-
Evolving spectrum of diabetic nephropathy.World J Diabetes. 2019 May 15;10(5):269-279. doi: 10.4239/wjd.v10.i5.269. World J Diabetes. 2019. PMID: 31139314 Free PMC article. Review.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous